In CLL cells, MDM2 has been reported to be over-expressed in 28% of CLL cases, suggesting an excellent potential for inducing cell death by inhibiting MDM2 activity. The gene discussed is MDM2; the disease is B-cell chronic lymphocytic leukemia.